Accessibility Menu
 
OrthoPediatrics logo

OrthoPediatrics

(NASDAQ) KIDS

Current Price$16.07
Market Cap$405.98M
Since IPO (2017)-16%
5 Year-68%
1 Year-39%
1 Month-14%

OrthoPediatrics Financials at a Glance

Market Cap

$405.98M

Revenue (TTM)

$236.35M

Net Income (TTM)

$39.65M

EPS (TTM)

$-1.69

P/E Ratio

-9.50

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$16.07

Volume

10,758

Open

$16.16

Previous Close

$16.07

Daily Range

$15.61 - $16.21

52-Week Range

$14.91 - $23.96

KIDS: Motley Fool Moneyball Superscore

63

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About OrthoPediatrics

Industry

Healthcare Equipment and Supplies

Employees

602

CEO

David R. Bailey

Headquarters

Warsaw, IN 46582, US

KIDS Financials

Key Financial Metrics (TTM)

Gross Margin

73%

Operating Margin

-12%

Net Income Margin

-17%

Return on Equity

-11%

Return on Capital

-6%

Return on Assets

-8%

Earnings Yield

-10.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$405.98M

Shares Outstanding

25.28M

Volume

10.76K

Short Interest

0.00%

Avg. Volume

158.18K

Financials (TTM)

Gross Profit

$172.66M

Operating Income

$29.00M

EBITDA

$7.88M

Operating Cash Flow

$4.85M

Capital Expenditure

$11.11M

Free Cash Flow

$15.96M

Cash & ST Invst.

$60.85M

Total Debt

$48.36M

OrthoPediatrics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$61.60M

+17.0%

Gross Profit

$45.11M

+26.8%

Gross Margin

73.22%

N/A

Market Cap

$405.98M

N/A

Market Cap/Employee

$722.38K

N/A

Employees

562

N/A

Net Income

$10.10M

+37.1%

EBITDA

$1.96M

+142.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$12.49M

+203.5%

Accounts Receivable

$53.84M

+27.1%

Inventory

$133.79M

+14.3%

Long Term Debt

$48.19M

-38.7%

Short Term Debt

$170.00K

-92.5%

Return on Assets

-7.58%

N/A

Return on Invested Capital

-6.08%

N/A

Free Cash Flow

$9.75M

+361.7%

Operating Cash Flow

$10.35M

+359.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LABStandard BioTools Inc.
$0.91-1.13%
SMLRSemler Scientific, Inc.
$20.33-4.87%
TOIThe Oncology Institute, Inc.
$3.12-0.64%
RXSTRxSight, Inc.
$6.64+4.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
SKYQSky Quarry
$5.10+1.02%
NVDANvidia
$177.39+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.37-0.11%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.33+0.00%

Questions About KIDS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.